Choosing preclinical study models of diabetic retinopathy: key problems for consideration

Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo a...

Full description

Saved in:
Bibliographic Details
Published inDrug design, development and therapy Vol. 8; no. default; pp. 2311 - 2319
Main Authors Mi, Xuesong, Yuan, Ti-Fei, Zhong, Jing-Xiang, Ding, Yong, So, Kwok-Fai
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2014
Taylor & Francis Ltd
Dove Press
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR.
AbstractList Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR.
Xue-Song Mi,1,2 Ti-Fei Yuan,3,4 Yong Ding,1 Jing-Xiang Zhong,1 Kwok-Fai So4,5 1Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China; 2Department of Anatomy, Li Ka Shing Faculty ofMedicine, The University of Hong Kong, Hong Kong, People's Republic ofChina; 3School of Psychology, Nanjing Normal University, Nanjing, People's Republic of China; 4Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; 5Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People's Republic of China Abstract: Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. Keywords: animal model, in vitro culture, ex vivo culture, neurovascular dysfunction
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR. Keywords: animal model, in vitro culture, ex vivo culture, neurovascular dysfunction
Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR.Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a relative high level, there are still many urgent problems that need to be investigated in clinical and basic science. Currently, many in vivo animal models and in vitro culture systems have been applied to solve these problems. Many approaches have also been used to establish different DR models. However, till now, there has not been a single study model that can clearly and exactly mimic the developmental process of the human DR. Choosing the suitable model is important, not only for achieving our research goals smoothly, but also, to better match with different experimental proposals in the study. In this review, key problems for consideration in choosing study models of DR are discussed. These problems relate to clinical relevance, different approaches for establishing models, and choice of different species of animals as well as of the specific in vitro culture systems. Attending to these considerations will deepen the understanding on current study models and optimize the experimental design for the final goal of preventing DR.
Audience Academic
Author Zhong, Jing-Xiang
Ding, Yong
So, Kwok-Fai
Yuan, Ti-Fei
Mi, Xuesong
AuthorAffiliation 4 Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
5 Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People’s Republic of China
2 Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China
1 Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People’s Republic of China
3 School of Psychology, Nanjing Normal University, Nanjing, People’s Republic of China
AuthorAffiliation_xml – name: 4 Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong
– name: 1 Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People’s Republic of China
– name: 3 School of Psychology, Nanjing Normal University, Nanjing, People’s Republic of China
– name: 2 Department of Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China
– name: 5 Guangdong-Hongkong-Macau Institute of Central Nervous System, Jinan University, Guangzhou, People’s Republic of China
Author_xml – sequence: 1
  givenname: Xuesong
  surname: Mi
  fullname: Mi, Xuesong
– sequence: 2
  givenname: Ti-Fei
  surname: Yuan
  fullname: Yuan, Ti-Fei
– sequence: 3
  givenname: Jing-Xiang
  surname: Zhong
  fullname: Zhong, Jing-Xiang
– sequence: 4
  givenname: Yong
  surname: Ding
  fullname: Ding, Yong
– sequence: 5
  givenname: Kwok-Fai
  surname: So
  fullname: So, Kwok-Fai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25429204$$D View this record in MEDLINE/PubMed
BookMark eNqNU02L2zAUNGVL96M99V4MhVIoSfVhyXYPhSXpx8JCD90eehKy_BQrlaVUshfy76skmzYJeygGWzzPjMfz3rvMzpx3kGUvMZoSXJTv5_P53fR7Scq6fJJdYFyWk6qq8NnB-Ty7jHGJEKecoGfZOWEFqQkqLrKfs877aNwiXwVQ1jijpM3jMLbrvPct2Jh7nbdGNjAYlYd0d34lh279If8F68TyjYU-5tqHXHkXTQtBDsa759lTLW2EFw_Pq-zH5093s6-T229fbmbXtxNVYjpMOK90BW3VNFVTS6oLgKKRpFAUK0QJUVS3rW4lZQRUxTXnXJFGKV0SxLis6VV2s9NtvVyKVTC9DGvhpRHbgg8LIUPybkFwrWqUtFTFZApAy4YxSoCVssRYMpq0Pu60VmPTQ6vADUHaI9HjN850YuHvRUEKgulGAO3N3ENKNMYTR_uq8r3AqQU4Ud4-fDP43yPEQfQmKrBWOvBjFJhThjCrt_b-B4oJLxP09Ql06cfgUiMEIbRiGPOK_UMtZIrHOO3TX6mNqLguEEY14wgl1PQRVLpa6E3qOWiT6keENweEDqQduujtuBmLeAx8dZj336z285kAeAdQwccYQAtlhu14JQvGCozEZgfEZgfEbgcS590JZy_7GPoPE9cHEg
CitedBy_id crossref_primary_10_3389_fphar_2021_811818
crossref_primary_10_7717_peerj_11316
crossref_primary_10_3892_mmr_2019_9863
crossref_primary_10_3390_antiox9060561
crossref_primary_10_3390_ijtm2010001
crossref_primary_10_2302_kjm_2021_0004_IR
ContentType Journal Article
Copyright COPYRIGHT 2014 Dove Medical Press Limited
2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2014 Mi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014
Copyright_xml – notice: COPYRIGHT 2014 Dove Medical Press Limited
– notice: 2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2014 Mi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7RV
7XB
8FD
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
KB0
M2O
MBDVC
NAPCQ
P64
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/DDDT.S72797
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Nursing & Allied Health Database
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
Nursing & Allied Health Database (Alumni Edition)
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Biotechnology Research Abstracts
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Engineering Research Database



MEDLINE - Academic


Publicly Available Content Database
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1177-8881
EndPage 2319
ExternalDocumentID oai_doaj_org_article_6fc90fdac85a429fab5532e57a711a53
PMC4242133
oai_dovepress_com_19201
A401095600
25429204
10_2147_DDDT_S72797
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GeographicLocations Spain
Hong Kong
China
GeographicLocations_xml – name: Spain
– name: China
– name: Hong Kong
GroupedDBID ---
0YH
29G
2WC
53G
5GY
5VS
7RV
8FI
8FJ
8G5
AAYXX
ABUWG
ACGFO
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFKRA
AFRAH
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BKEYQ
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EMOBN
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ITC
KQ8
M2O
M48
MK0
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RPM
SV3
TDBHL
TR2
UKHRP
VDV
CGR
CUY
CVF
ECM
EIF
NPM
PPXIY
PMFND
3V.
7QO
7XB
8FD
8FK
FR3
MBDVC
P64
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
-
ADACO
BBAFP
LI0
5PM
PUEGO
ID FETCH-LOGICAL-c713t-668f8ed8bb8b9a3f4ee4ba24c31c0322c3fddfda352ec86f666c2bccf72056a93
IEDL.DBID M48
ISSN 1177-8881
IngestDate Wed Aug 27 01:07:04 EDT 2025
Thu Aug 21 14:34:40 EDT 2025
Mon Jan 18 10:57:31 EST 2021
Fri Jul 11 01:46:51 EDT 2025
Fri Jul 11 03:55:24 EDT 2025
Sat Jul 26 02:19:34 EDT 2025
Tue Jun 17 21:47:05 EDT 2025
Tue Jun 10 20:28:26 EDT 2025
Thu May 22 21:19:47 EDT 2025
Mon Jul 21 06:08:45 EDT 2025
Tue Jul 01 01:57:56 EDT 2025
Thu Apr 24 22:57:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue default
Keywords neurovascular dysfunction
ex vivo culture
animal model
in vitro culture
Language English
License http://creativecommons.org/licenses/by-nc/3.0
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c713t-668f8ed8bb8b9a3f4ee4ba24c31c0322c3fddfda352ec86f666c2bccf72056a93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/DDDT.S72797
PMID 25429204
PQID 2238511685
PQPubID 2046454
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_6fc90fdac85a429fab5532e57a711a53
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4242133
dovepress_primary_oai_dovepress_com_19201
proquest_miscellaneous_1635015953
proquest_miscellaneous_1635011267
proquest_journals_2238511685
gale_infotracmisc_A401095600
gale_infotracacademiconefile_A401095600
gale_healthsolutions_A401095600
pubmed_primary_25429204
crossref_citationtrail_10_2147_DDDT_S72797
crossref_primary_10_2147_DDDT_S72797
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Macclesfield
PublicationTitle Drug design, development and therapy
PublicationTitleAlternate Drug Des Devel Ther
PublicationYear 2014
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove Press
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove Press
– name: Dove Medical Press
References 24936248 - World J Diabetes. 2014 Jun 15;5(3):267-81
22915034 - Invest Ophthalmol Vis Sci. 2012 Sep;53(10):6488-94
17003462 - Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4638-45
22593752 - Front Neurol. 2012 May 11;3:75
11399456 - Comp Biochem Physiol B Biochem Mol Biol. 2001 Jun;129(2-3):243-9
8603874 - Invest Ophthalmol Vis Sci. 1996 Apr;37(5):898-905
21127484 - Nat Protoc. 2010 Dec;5(12):1903-10
2062510 - Ophthalmology. 1991 May;98(5 Suppl):741-56
25017009 - Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):527-35
24664757 - Adv Exp Med Biol. 2014;801:669-75
17365659 - Microcirculation. 2007 Jan;14(1):25-38
21635964 - Prog Retin Eye Res. 2011 Sep;30(5):343-58
880082 - Arch Ophthalmol. 1977 Jul;95(7):1215-20
21394065 - Retina. 2011 Apr;31(4):673-8
23786217 - J Biomed Sci. 2013;20:38
22553559 - Int J Ophthalmol. 2010;3(3):224-7
22212972 - Mayo Clin Proc. 2012 Jan;87(1):77-88
18442090 - Glia. 2008 Aug 1;56(10):1076-90
22911805 - PLoS One. 2012;7(7):e41511
23221078 - Invest Ophthalmol Vis Sci. 2013 Jan;54(1):574-84
13129861 - Ophthalmology. 2003 Sep;110(9):1677-82
21658386 - Exp Eye Res. 2011 Jul;93(1):108-13
8110701 - Br J Ophthalmol. 1994 Jan;78(1):54-60
25029255 - PLoS One. 2014;9(7):e102309
21192081 - J Comp Neurol. 2011 Feb 15;519(3):506-27
22302382 - Angiogenesis. 2012 Jun;15(2):171-85
8738706 - Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):388-98
11473058 - Diabetes. 2001 Aug;50(8):1938-42
24933041 - Prog Retin Eye Res. 2014 Sep;42:103-29
11729961 - Ital J Anat Embryol. 2001;106(2 Suppl 1):237-44
7742285 - Br J Ophthalmol. 1995 Apr;79(4):362-7
24809388 - Expert Opin Drug Saf. 2014 Jun;13(6):785-802
21307645 - Oxid Med Cell Longev. 2010 Nov-Dec;3(6):392-403
23716429 - Magn Reson Med. 2014 Apr;71(4):1526-30
22945600 - Doc Ophthalmol. 2012 Dec;125(3):235-47
23485060 - Clin Sci (Lond). 2013 Jul;125(1):1-17
20335444 - Dis Model Mech. 2010 May-Jun;3(5-6):343-53
21293735 - Mol Vis. 2011;17:300-8
22503301 - Ophthalmology. 2012 Aug;119(8):1679-84
16249509 - Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4281-7
24531025 - Am J Ophthalmol. 2014 May;157(5):960-70
20727883 - Exp Eye Res. 2010 Nov;91(5):670-5
15557466 - Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4543-53
22969284 - Clin Ophthalmol. 2012;6:1393-7
22402950 - Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201
22044044 - Diabetes Technol Ther. 2012 Mar;14(3):257-63
24121991 - Angiogenesis. 2014 Jul;17(3):429-42
24286086 - J Diabetes Res. 2013;2013:106594
20070152 - Ultrastruct Pathol. 2010 Feb;34(1):35-41
22729438 - Invest Ophthalmol Vis Sci. 2012 Aug;53(8):4910-6
23790257 - Expert Opin Pharmacother. 2013 Sep;14(13):1829-38
18220619 - Curr Diabetes Rev. 2006 Feb;2(1):71-98
17267004 - Vision Res. 2007 Mar;47(5):612-23
4064731 - Curr Eye Res. 1985 Oct;4(10):1087-92
20829433 - Am J Pathol. 2010 Nov;177(5):2659-70
19729434 - J Am Soc Nephrol. 2009 Dec;20(12):2503-12
12586175 - Jpn J Ophthalmol. 2003 Jan-Feb;47(1):28-35
8529097 - Mol Med. 1995 Jan;1(2):182-93
18996116 - Exp Eye Res. 2009 Jan;88(1):106-12
14654976 - Int J Mol Med. 2004 Jan;13(1):87-92
25055729 - J Diabetes Complications. 2014 Nov-Dec;28(6):767-71
21750018 - Exp Biol Med (Maywood). 2011 Sep;236(9):1051-63
12875445 - J Am Vet Med Assoc. 2003 Jul 15;223(2):198-201
22897941 - Stem Cell Res Ther. 2012;3(4):31
23032068 - Int Immunopharmacol. 2012 Dec;14(4):606-12
7887849 - Arch Ophthalmol. 1995 Mar;113(3):352-4
9227268 - Exp Eye Res. 1997 Apr;64(4):505-17
19940532 - Ophthalmologica. 2010;224(4):243-6
25038518 - Prog Retin Eye Res. 2014 Nov;43:17-75
19238311 - Acta Diabetol. 2010 Mar;47(1):59-64
24457359 - Br J Ophthalmol. 2014 May;98(5):675-8
23766636 - Clin Interv Aging. 2013;8:467-83
7691433 - Brain Res Dev Brain Res. 1993 Aug 20;74(2):207-17
9721595 - Pharmacol Res. 1998 Aug;38(2):97-100
22610144 - Doc Ophthalmol. 2012 Aug;125(1):31-42
20655908 - Exp Eye Res. 2010 Oct;91(4):530-6
11110039 - J Ocul Pharmacol Ther. 2000 Oct;16(5):471-9
25097467 - Clin Proteomics. 2014 Jul 14;11(1):29
18235022 - Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42
23807371 - JAMA Ophthalmol. 2013 Aug;131(8):1033-40
1713023 - Am J Pathol. 1991 Jul;139(1):81-100
24503724 - Eye (Lond). 2014 Apr;28(4):367-80
20840523 - Wound Repair Regen. 2010 Sep-Oct;18(5):532-42
10420122 - Ophthalmic Res. 1999;31(5):367-77
17574431 - Pharmacol Res. 2007 Jun;55(6):498-510
20445540 - Nature. 2010 May 27;465(7297):487-91
21191444 - Clin Ophthalmol. 2010 Dec 08;4:1481-8
15977012 - Diabetologia. 2005 Aug;48(8):1663-8
References_xml – reference: 7691433 - Brain Res Dev Brain Res. 1993 Aug 20;74(2):207-17
– reference: 24121991 - Angiogenesis. 2014 Jul;17(3):429-42
– reference: 23485060 - Clin Sci (Lond). 2013 Jul;125(1):1-17
– reference: 22945600 - Doc Ophthalmol. 2012 Dec;125(3):235-47
– reference: 23032068 - Int Immunopharmacol. 2012 Dec;14(4):606-12
– reference: 18220619 - Curr Diabetes Rev. 2006 Feb;2(1):71-98
– reference: 22915034 - Invest Ophthalmol Vis Sci. 2012 Sep;53(10):6488-94
– reference: 22553559 - Int J Ophthalmol. 2010;3(3):224-7
– reference: 11473058 - Diabetes. 2001 Aug;50(8):1938-42
– reference: 8603874 - Invest Ophthalmol Vis Sci. 1996 Apr;37(5):898-905
– reference: 20840523 - Wound Repair Regen. 2010 Sep-Oct;18(5):532-42
– reference: 22212972 - Mayo Clin Proc. 2012 Jan;87(1):77-88
– reference: 23716429 - Magn Reson Med. 2014 Apr;71(4):1526-30
– reference: 23786217 - J Biomed Sci. 2013;20:38
– reference: 8529097 - Mol Med. 1995 Jan;1(2):182-93
– reference: 22969284 - Clin Ophthalmol. 2012;6:1393-7
– reference: 22044044 - Diabetes Technol Ther. 2012 Mar;14(3):257-63
– reference: 9721595 - Pharmacol Res. 1998 Aug;38(2):97-100
– reference: 23221078 - Invest Ophthalmol Vis Sci. 2013 Jan;54(1):574-84
– reference: 11729961 - Ital J Anat Embryol. 2001;106(2 Suppl 1):237-44
– reference: 12586175 - Jpn J Ophthalmol. 2003 Jan-Feb;47(1):28-35
– reference: 1713023 - Am J Pathol. 1991 Jul;139(1):81-100
– reference: 24664757 - Adv Exp Med Biol. 2014;801:669-75
– reference: 22729438 - Invest Ophthalmol Vis Sci. 2012 Aug;53(8):4910-6
– reference: 24457359 - Br J Ophthalmol. 2014 May;98(5):675-8
– reference: 20070152 - Ultrastruct Pathol. 2010 Feb;34(1):35-41
– reference: 24933041 - Prog Retin Eye Res. 2014 Sep;42:103-29
– reference: 21658386 - Exp Eye Res. 2011 Jul;93(1):108-13
– reference: 20335444 - Dis Model Mech. 2010 May-Jun;3(5-6):343-53
– reference: 24809388 - Expert Opin Drug Saf. 2014 Jun;13(6):785-802
– reference: 11399456 - Comp Biochem Physiol B Biochem Mol Biol. 2001 Jun;129(2-3):243-9
– reference: 15557466 - Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4543-53
– reference: 24936248 - World J Diabetes. 2014 Jun 15;5(3):267-81
– reference: 23790257 - Expert Opin Pharmacother. 2013 Sep;14(13):1829-38
– reference: 24531025 - Am J Ophthalmol. 2014 May;157(5):960-70
– reference: 24503724 - Eye (Lond). 2014 Apr;28(4):367-80
– reference: 11110039 - J Ocul Pharmacol Ther. 2000 Oct;16(5):471-9
– reference: 18235022 - Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42
– reference: 10420122 - Ophthalmic Res. 1999;31(5):367-77
– reference: 21635964 - Prog Retin Eye Res. 2011 Sep;30(5):343-58
– reference: 17365659 - Microcirculation. 2007 Jan;14(1):25-38
– reference: 7887849 - Arch Ophthalmol. 1995 Mar;113(3):352-4
– reference: 25097467 - Clin Proteomics. 2014 Jul 14;11(1):29
– reference: 20655908 - Exp Eye Res. 2010 Oct;91(4):530-6
– reference: 19238311 - Acta Diabetol. 2010 Mar;47(1):59-64
– reference: 24286086 - J Diabetes Res. 2013;2013:106594
– reference: 21293735 - Mol Vis. 2011;17:300-8
– reference: 13129861 - Ophthalmology. 2003 Sep;110(9):1677-82
– reference: 16249509 - Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4281-7
– reference: 23807371 - JAMA Ophthalmol. 2013 Aug;131(8):1033-40
– reference: 23766636 - Clin Interv Aging. 2013;8:467-83
– reference: 12875445 - J Am Vet Med Assoc. 2003 Jul 15;223(2):198-201
– reference: 22593752 - Front Neurol. 2012 May 11;3:75
– reference: 21127484 - Nat Protoc. 2010 Dec;5(12):1903-10
– reference: 7742285 - Br J Ophthalmol. 1995 Apr;79(4):362-7
– reference: 17574431 - Pharmacol Res. 2007 Jun;55(6):498-510
– reference: 25017009 - Graefes Arch Clin Exp Ophthalmol. 2015 Apr;253(4):527-35
– reference: 15977012 - Diabetologia. 2005 Aug;48(8):1663-8
– reference: 21192081 - J Comp Neurol. 2011 Feb 15;519(3):506-27
– reference: 17003462 - Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4638-45
– reference: 25055729 - J Diabetes Complications. 2014 Nov-Dec;28(6):767-71
– reference: 22897941 - Stem Cell Res Ther. 2012;3(4):31
– reference: 25029255 - PLoS One. 2014;9(7):e102309
– reference: 22911805 - PLoS One. 2012;7(7):e41511
– reference: 22402950 - Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):199-201
– reference: 8110701 - Br J Ophthalmol. 1994 Jan;78(1):54-60
– reference: 21394065 - Retina. 2011 Apr;31(4):673-8
– reference: 2062510 - Ophthalmology. 1991 May;98(5 Suppl):741-56
– reference: 21191444 - Clin Ophthalmol. 2010 Dec 08;4:1481-8
– reference: 880082 - Arch Ophthalmol. 1977 Jul;95(7):1215-20
– reference: 18996116 - Exp Eye Res. 2009 Jan;88(1):106-12
– reference: 19940532 - Ophthalmologica. 2010;224(4):243-6
– reference: 21750018 - Exp Biol Med (Maywood). 2011 Sep;236(9):1051-63
– reference: 9227268 - Exp Eye Res. 1997 Apr;64(4):505-17
– reference: 20445540 - Nature. 2010 May 27;465(7297):487-91
– reference: 8738706 - Graefes Arch Clin Exp Ophthalmol. 1996 Jun;234(6):388-98
– reference: 25038518 - Prog Retin Eye Res. 2014 Nov;43:17-75
– reference: 18442090 - Glia. 2008 Aug 1;56(10):1076-90
– reference: 17267004 - Vision Res. 2007 Mar;47(5):612-23
– reference: 14654976 - Int J Mol Med. 2004 Jan;13(1):87-92
– reference: 20829433 - Am J Pathol. 2010 Nov;177(5):2659-70
– reference: 19729434 - J Am Soc Nephrol. 2009 Dec;20(12):2503-12
– reference: 4064731 - Curr Eye Res. 1985 Oct;4(10):1087-92
– reference: 22302382 - Angiogenesis. 2012 Jun;15(2):171-85
– reference: 22610144 - Doc Ophthalmol. 2012 Aug;125(1):31-42
– reference: 21307645 - Oxid Med Cell Longev. 2010 Nov-Dec;3(6):392-403
– reference: 20727883 - Exp Eye Res. 2010 Nov;91(5):670-5
– reference: 22503301 - Ophthalmology. 2012 Aug;119(8):1679-84
SSID ssj0063620
Score 2.0345452
SecondaryResourceType review_article
Snippet Diabetic retinopathy (DR) is the most common complication of diabetes mellitus in the eye. Although the clinical treatment for DR has already developed to a...
Xue-Song Mi,1,2 Ti-Fei Yuan,3,4 Yong Ding,1 Jing-Xiang Zhong,1 Kwok-Fai So4,5 1Department of Ophthalmology, First Affiliated Hospital of Jinan University,...
SourceID doaj
pubmedcentral
dovepress
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2311
SubjectTerms Angiogenesis
animal model
Animal models
Animal models in research
Animals
Culture
Design of experiments
Design optimization
Diabetes
Diabetes mellitus
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 2 - complications
Diabetic retinopathy
Diabetic Retinopathy - complications
Diabetic Retinopathy - drug therapy
Disease Models, Animal
Edema
ex vivo culture
Experimental design
Eye surgery
Humans
Hyperglycemia
Hypotheses
in vitro culture
In vivo methods and tests
Medical imaging
Medical research
neurovascular dysfunction
Pathogenesis
Prevention
Researchers
Retina
Retinopathy
Review
Tumor necrosis factor-TNF
Vascular endothelial growth factor
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA_SF_VB_Ha1aoRSUbp0v5LN-lZ7liIoBa9Qn0I-aaHsinsV7r93Jtnd3qrQF1-TueMyM5n5JZf5DSE7lteQGJoyra0oU0DgLtWQClKmC8W50RA1sd75y1d-fFp9PmNnG62-8E1YpAeOitvn3jSZt8oIpiB2eqUZKwvHalXnuWKB5xNy3niYijGYQ1jOYlsViMFC5LEyD3vy7FtrYbdC2kaep41cFCj775LbtvsV36D-HaQ3stT8BeVGSjq6T-4NWJIexDU8ILdc-5DsnkQy6vUeXV7XVvV7dJeeXNNUrx-R74fnXYc3BRR-x1ggSQPdLA39cXraeRrvZi8MxWrHtsMGxusPFHY-HVrR9BRgLzVD389g58fk9OjT8vA4HRotpAbOqKuUc-GFs0JroRtV-sq5SquiMmVuMtjxpvTWgg0ArDkjuIcjjym0Mb4uAD-ppnxCttqudc8IRUjhtOdFA-aCo4pSouGVYA0MaUCTCXk_qlyagYUcm2FcSjiNoH3kYrFYym_BPgnZmYR_RPKNf4t9RNtNIsiYHQbAj-TgR_ImP0rIu8nyf3zTOAohQMISsjwhr9EzZCxVnWKEPKjwj0bEkAl5GyQwSsDyjBqKHUBJyLc1k9yeScLuNvPp0fvkEF16CZAOgTIXLCFvpmn8JL6Ya1131UvA2SzD-rD6JhnW4OqfRoeell7ERmZVQuqZq890M59pL84DP3mFzwzK8vn_MMsLcgcUXsVLr22ytfp55V4CDFzpV2HH_wa3WFym
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgewAeEN8EBhhpGgItrE1ix-EFbeumCYmpgk7anizbsdkklIylQ-p_z13spA0geLWvle3z3f18uQ9CNkueg2Eo0jgvRRoDArexBlMQM50ozo0GrYn5zp-P-dFJ9umUnQaHWxPCKjud2CrqsjboI98BM4bggAv28fJHjF2j8OtqaKFxk6yDChbw-FrfOzieful0MQf1PPJZediPZ2cymczefwWTjTWeVuxQW67_DrlV1j99_OmfCnrFQg2jJ1fM0eE9cjfgSLrrGX-f3LDVA7I19YWoF9t0tsyrarbpFp0uS1QvHpKz_fO6Ri8BhXV0yZG0LTVL2944Da0d9X7ZC0Mx07GqsXnx4gMFqaehDU1DAfJSE3p-tjx-RE4OD2b7R3FoshAbeJ_OY86FE7YUWgtdqNRl1mZaJZlJx2YE0m5SV5auVADUrBHcwXPHJNoYlyeAnVSRPiZrVV3Zp4QinLDa8aRgKoNnilKi4JlgBQxpQJIRedcduTShAjk2wvgu4SWC_JHIH-n5E5HNnvjSF974O9ke8q4nwWrZ7UB99U0G4ZPcmWIEezACFpYUTmnG0sSyXOXjsWJpRN72nP_tn7pRuIoStjAaR-QV3gzp01R7_SB3M_zIiPgxIm9aCtQQsD2jQqIDHBLW2hpQbgwoQbLNcLq7fTJolkYu5SAir_tp_CVGy1W2vm4kYGw2wtyw_H80rMDdP_EXut964puYZRHJB1d9cDbDmerivK1NnmGIQZo--_fSn5PbcJSZd2VtkLX51bV9AeBurl8GCf4F7mRSkg
  priority: 102
  providerName: ProQuest
Title Choosing preclinical study models of diabetic retinopathy: key problems for consideration
URI https://www.ncbi.nlm.nih.gov/pubmed/25429204
https://www.proquest.com/docview/2238511685
https://www.proquest.com/docview/1635011267
https://www.proquest.com/docview/1635015953
http://www.dovepress.com/getfile.php?fileID=22470
https://pubmed.ncbi.nlm.nih.gov/PMC4242133
https://doaj.org/article/6fc90fdac85a429fab5532e57a711a53
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3_a9QwFA9z-0H9QfxudZ4RxkRZ57VN0lQQ2XYbQ9g49A7mTyFJUzcYrd7dxPvvfa9pu3UO9NfktTTv6ydp3nuEbOQihcCQJWGayyQEBO5CA6Eg5CbWQlgDXhPznY-OxeGUfT7hJyukbcbZMHB-49YO-0lNZ-fbv38uP4HBf8RrzBFL349Go8n2VwjEWXqLrEFIStFCj1j3O0GAlx76LivgkqWMfKLe9Yd7oamu4H-X3M6rX_5K6t8--0rQ6l-ovBKhDu6Tew20pDteFx6QFVc-JJtjX5t6uUUnl6lW8y26SceXVauXj8i3vdOqwoMDCt_R5kvSuvosrdvlzGlVUH9Ue2YpJj-WFfYzXn6g4Aho05lmTgEFU9u0Aa3F_phMD_Yne4dh03chtLBlXYRCyEK6XBojTaaTgjnHjI6ZTSI7BAdgkyLPi1wDdnNWigJ2QDY21hZpDHBKZ8kTslpWpXtGKCIMZwoRZ1wz2LloLTPBJM9gyAC4DMi7luXKNkXJsTfGuYLNCcpHoXyUl09ANjriH74Wx81kuyi7jgQLaNcD1ey7auxRicJmQ1iDlfBhcVZow3kSO57qNIo0TwLytpP8tTe1o-ARFCxhGAXkFWqG8pmrnctQOwz_OyKkDMibmgLVGJZndZP7AEzC8ls9yvUeJRi77U-32qdaW1GA8BA3C8kD8rqbxifxAl3pqou5AtjNh5gulv6Lhme4-qdeobulx76vGQtI2lP1Hm_6M-XZaV2unOGtgyR5_n_Se0HuAEuZP-VaJ6uL2YV7CbhvYQZkbXf_ePxlUJ-bDGoL_wNuCFn1
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9N28PgAfFNYDAjjSHQwtp8OAkSQtu6qWNbVbFOGk_Gdhw2CSVj7UD9p_gbuYuTtAEET3u1r5XtO9_97PjuB7CW8ggDQ-K7URr7LiJw4yoMBW6oPMm5Vug1Kd_5aMD7J8GH0_B0AX7WuTD0rLL2iaWjTgtNd-SbGMYIHPA4fH_xzSXWKPq6WlNoWLM4MNMfeGQbv9vvoX5feN7e7min71asAq7GA9nE5TzOYpPGSsUqkX4WGBMo6QXa7-oOmrf2szTNUonIxOiYZ4jvtae0ziIPwYKk4kvo8pcCH48yi7C0vTsYfqx9P8dw0LFZgMT_s9nr9UZvjhEiUE2pubhX0gPchOW0-G7fu_4ZEOYiYvu15lz427sNtyrcyrasod2BBZPfhfWhLXw93WCjWR7XeIOts-GsJPb0HnzaOSsKupVgOI46GZOVpW1ZycUzZkXG7D3wuWaUWZkXRJY8fcvQy7CK9mbMEGIzXXGMljZ1H06uZfkfwGJe5OYRMIIvRmXcS0IZ4LFIyjjhQRwm2KQQuTrwul5yoauK50S88VXgyYf0I0g_wurHgbVG-MIW-vi72DbprhGh6txlQ3H5RVSbXfBMJx2cg45xYF6SSRWGvmfCSEbdrgx9B141mv_tn-pWNH2BU-h0HVglyxA2LbbxR2IroI-ahFcdeFlKkEfC6WlZJVbgIlFtr5bkSksSPYlud9fWJypPNhazfefA86abfkmv83JTXI0FYvqwQ7lo0f9kwoRm_9AadDN1z5KmBQ5ELVNvrU27Jz8_K2uhB_Skwfcf_3voq7DcHx0disP9wcETuIHLGthrtBVYnFxemacILCfqWbWbGXy-bgfyC45fkXk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTeLjAfFNYDAjjSHQQtMkdhIkhLZ11cagqkYnjSdjOw6bhJKxdKD-a_x13MVJ2gCCp73a18q-O9_97NwHIespj8AxJIEbpXHgAgI3rgJX4DLlS861AquJ-c4fRnzvKHx3zI6XyM8mFwbDKhubWBnqtND4Rt4DN4bggMesl9VhEePB8O3ZNxc7SOGX1qadhlWRAzP7Ade38s3-AGT9zPeHu5OdPbfuMOBquJxNXc7jLDZprFSsEhlkoTGhkn6og772QNV1kKVplkpAKUbHPAOsr32ldRb5ABwkFmIC878Swa3IWyYr27uj8WHjBzi4Bs9mBGIvoN5gMJi8-ghwAetLLfjAqlXAdXI1Lb7b2Nc_ncOCd-xGbi64wuFNcqPGsHTLKt0tsmTy22RjbItgzzbpZJ7TVW7SDTqel8ee3SGfdk6KAl8oKKyjScykVZlbWvXlKWmRUfsmfKopZlnmBTZOnr2mYHFo3QKnpAC3qa77jVb6dZccXQr775HlvMjNA0IRyhiVcT9hMoQrkpRxwsOYJTCkAMU65GXDcqHr6ufYhOOrgFsQykegfISVj0PWW-IzW_Tj72TbKLuWBCt1VwPF-RdRH3zBM514sAcdw8L8JJOKscA3LJJRvy9Z4JAXreR_-6dmFI6BgC14fYesoWYImyLb2iaxFeIHTsSuDnleUaB1gu1pWSdZAJOwzleHcrVDCVZFd6cb7RO1VSvF_Aw65Gk7jb_ESL3cFBelAHzPPMxLi_5HwxLc_X2r0O3WfdtALXRI1FH1Dm-6M_npSVUXPcTwhiB4-O-lr5ErYDjE-_3RwSNyDbga2he1VbI8Pb8wjwFjTtWT-jBT8vmy7ccvE3CVrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Choosing+preclinical+study+models+of+diabetic+retinopathy%3A+key+problems+for+consideration&rft.jtitle=Drug+design%2C+development+and+therapy&rft.au=Mi%2C+Xuesong&rft.au=Yuan%2C+Ti-Fei&rft.au=Zhong%2C+Jing-Xiang&rft.au=Ding%2C+Yong&rft.date=2014-01-01&rft.issn=1177-8881&rft.eissn=1177-8881&rft.spage=2311&rft_id=info:doi/10.2147%2FDDDT.S72797&rft.externalDBID=n%2Fa&rft.externalDocID=10_2147_DDDT_S72797
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1177-8881&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1177-8881&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1177-8881&client=summon